Skip to main content
Second Regular Session | 75th General Assembly
Colorado General Assembly

CLICS/CLICS2026A/commsumm.nsf
PUBLIC
BILL SUMMARY For SB26-140

HOUSE COMMITTEE ON HEALTH & HUMAN SERVICES
Date Apr 22, 2026       Location HCR 0112

SB26-140 -


02:57:15 PM  
The primary bill sponsors, Representatives Gilchrist and Johnson, introduced Senate Bill 26-140 to the House Health and Human Services Committee. Under current law, the Prescription Drug Affordability Review Board in the Department of Regulatory Agencies is prohibited from performing affordability reviews of, or establishing upper payment limits for, certain prescription drugs. The bill adds the following drugs to these restrictions: drugs that are designated by the federal government for rare diseases or conditions; and licensed biological products that are derived from human whole blood or plasma as indicated on product labeling approved by the federal government.

A handout was provided to the committee (Attachment A).
03:04:51 PM  
Priya Telang, on behalf of Kim Johnson, representing themself, testified in opposition to the bill. Nikita Valdez, representing Centennial State Prosperity, testified in opposition to the bill. Mrs. Debbie Hornor, representing AARP Volunteer, testified in opposition to the bill. Dave Denovellis, representing Colorado Academy of Family Physicians, testified in opposition to the bill.
03:15:24 PM  
Ms. Sophia Hennessy, representing Colorado Consumer Health Initiative, testified in opposition to the bill. Lila Cummings, representing Division of Insurance, testified in opposition to the bill. Bethany Pray, representing Colorado Center on Law and Policy, testified in opposition to the bill. Laura Reinsch, representing themself, testified in opposition to the bill.
03:25:46 PM  
The panel responded to questions from the committee.
03:32:20 PM  
Stephanie Jaramillo, representing themself, testified in support of the bill. Mr. Perry Jowsey, representing Colorado Chapter, National Bleeding Disorders Foundation, testified in support of the bill. Ms. Kristy Kibler, representing Lupus Colorado, testified in support of the bill. Amanda Boone, representing Self, and CF United, testified in support of the bill.
03:43:40 PM  
Mrs. Bridget Dandaraw-Seritt, representing Advocates for Compassionate Therapy Now and Colorado Rare Disease Coalition, testified in support of the bill. Dr. Jessie Shay, representing Chronically Informed, testified in support of the bill. Jennifer Reinhardt, representing themself, testified in support of the bill. Ryan Boone, representing themself, testified in support of the bill. Ryder Boone, representing themself, testified in support of the bill. Jessica Myers, representing US Hereditary Angioedema Association, testified in support of the bill.

Additional written testimony was submitted to the committee (Attachment B).
03:59:09 PM  
The panel responded to questions from the committee.
03:59:52 PM  
The primary bill sponsors, Representatives Gilchrist and Johnson, provided closing comments on the bill.
04:04:26 PM  
Members of the committee provided closing comments on the bill.

Representative Gilchrist asked that the committee vote to lay Senate Bill 26-140 over until May 15th, 2026.

04:06:36 PM
 Motion Lay over the bill until May 15th.
Moved Gilchrist
Seconded Johnson
Barron Yes
Bradfield Yes
Bradley Yes
English Excused
Feret Yes
Hamrick Yes
Johnson Yes
McCormick Yes
Rydin Yes
Stewart K. Yes
Woog Excused
Lieder Yes
Gilchrist Yes
Final YES: 11   NO: 0   EXC: 2   ABS:  0   FINAL ACTION:  PASS